0001104659-22-109824.txt : 20221019
0001104659-22-109824.hdr.sgml : 20221019
20221019071813
ACCESSION NUMBER: 0001104659-22-109824
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221017
FILED AS OF DATE: 20221019
DATE AS OF CHANGE: 20221019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stein Steven H
CENTRAL INDEX KEY: 0001673776
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40869
FILM NUMBER: 221317225
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001745020
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830712806
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 314 MAIN STREET, SUITE 04-200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (857) 400-9491
MAIL ADDRESS:
STREET 1: 314 MAIN STREET, SUITE 04-200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
tm2228422-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-10-17
0
0001745020
Theseus Pharmaceuticals, Inc.
THRX
0001673776
Stein Steven H
C/O THESEUS PHARMACEUTICALS, INC.
314 MAIN STREET
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (right to buy)
5.97
2022-10-17
4
A
0
60000
0.00
A
2032-10-17
Common Stock
60000
60000
D
The options are subject to a service-based vesting requirement, which shall be satisfied over a three-year period with 1/36th of the options vesting on November 17, 2022 and 1/36th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer on each such vesting date.
/s/ Bradford Dahms - Attorney-in-Fact
2022-10-19